tirzepatide surmount-1 weight loss percent nejm 2022 Weight-Loss Titans: vs. Semaglutide in Obesity NEJM: Once-Weekly Semaglutide in Adults

In addition there is substantial research indicating neuroprotective effects of GLP-1RAs

Although these results are preliminary, they may provide justification for further studies in targeting CXCR3 in vitiligo (19), which proposes the use of a depleting Ab to create a greater clinical efficacy by removing autoreactive cells rather than modulating their migration phenotype

N nh mt cht bo ha tan c tc dng nh cht chng oxy ho

About the study The present study complies with ethical regulations and analyzes the Semaglutide Effects on Heart Disease and Stroke in Patients with Overweight or Obesity (SELECT) trial, a randomized, double-blind, placebo-controlled study

Zhang L, Zhang W, Tian X